Abstract | BACKGROUND: DATA SOURCE: RESULTS: CONCLUSION:
Antigen-based immune therapy with HBV-related antigens may be an alternative method for the treatment of CHB patients but proper designs of antigens, types of adjuvants, dose of vaccinations, and routes of administration need further analyses for the development of an effective regimen of immune therapy against HBV.
|
Authors | Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab, Mohammad Helal Uddin, Md Sakirul Islam Khan |
Journal | Hepatobiliary & pancreatic diseases international : HBPD INT
(Hepatobiliary Pancreat Dis Int)
Vol. 12
Issue 4
Pg. 363-9
(Aug 2013)
ISSN: 1499-3872 [Print] Singapore |
PMID | 23924493
(Publication Type: Journal Article, Review)
|
Chemical References |
- Antiviral Agents
- Cytokines
- Hepatitis B Core Antigens
- Hepatitis B Surface Antigens
- Hepatitis B Vaccines
- Intercellular Signaling Peptides and Proteins
|
Topics |
- Animals
- Antiviral Agents
(therapeutic use)
- Cytokines
(therapeutic use)
- Drug Therapy, Combination
- Hepatitis B Core Antigens
(immunology)
- Hepatitis B Surface Antigens
(immunology)
- Hepatitis B Vaccines
(therapeutic use)
- Hepatitis B, Chronic
(drug therapy, immunology)
- Humans
- Intercellular Signaling Peptides and Proteins
(therapeutic use)
|